Another molnupiravir drug authorised for use in COVID-19 treatment
Molnupiravir Stella 200mg, a drug produced and registered by Stellapharm J.V.Co. Ltd., has been authorised by the Drug Administration of Vietnam (DAV) for the domestic treatment of COVID-19.
There are now four Molnupiravir-based drugs produced in Vietnam approved for domestic use. (Photo: suckhoedoisong.vn)
Hanoi (VNA) - Molnupiravir Stella 200mg, a drug produced and registeredby Stellapharm J.V.Co. Ltd., has been authorised by the DrugAdministration of Vietnam (DAV) for the domestic treatment of COVID-19.
Thisis the fourth Molnupiravir-based drug produced in Vietnam to be authorised foruse in the country.
TheDAV orders manufacturers to adhere to documents registered with theMinistry of Health; coordinate with treatment facilities to strictly comply withcurrent regulations on prescription drugs, monitor the safety, effectiveness,and unwanted effects of drugs on Vietnamese people, as wellas compile reports according to regulations.
Atthe same time, the DAV also requested local departments of health notifymedical examination and treatment facilities, medical staff, and drug suppliersin the area to inform patients of the benefits and risks when usingMolnupiravir, including treatments, as well as alternatives for Molnupiravir inthe treatment of COVID-19.
Inaddition, it requires units to strengthen monitoring, supervision and detectionof cases of adverse drug reactions (if any), to send reports to the NationalCenter for Drug Information and Adverse Drug Reaction Monitoring (Hanoi) orRegional Center for Drug Information and Adverse Drug reaction monitoring (Ho ChiMinh City), according to regulations.
TheDAV orders the National Center for Drug Information and Adverse Drug ReactionsMonitoring-Hanoi University of Pharmacy, the Regional Center for Drug Informationand Adverse Drug Reactions Monitoring in HCM City-Cho Ray Hospital, and the Centerfor Clinical Pharmacology-Hanoi Medical University to be responsible formonitoring, updating and reporting the following information to the Department:
-Information in the leaflets for drugs containing Molnupiravir approved inreference countries around the world to update the unified instruction sheetfor Molnupiravir drugs.
-Information related to the safety and effectiveness of drugs containingMolnupiravir evaluated by pharmaceutical regulatory authorities in the world,World Health Organisation and information on the use and circulation status ofdrugs containing Molnupiravir worldwide.
-Information related to drug ADR reports and information on the safety and efficacyof drugs circulating in Vietnam.
Thedecision of the Drug Administration also states that in the course of drugcirculation, based on monitoring and updating information on the safety andeffectiveness of the three drugs above, the Drug Administration of Vietnam canrevoke the drug registration under the provisions of Clause 1, Article 58of the Law on Pharmacy./.
The Drug Administration of Vietnam (DAV) under the Ministry of Health on February 17 issued the list of three COVID-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.
The Drug Administration of Vietnam (DAV) under the Ministry of Health (MoH) has announced the prices of COVID-19 treatment drugs containing active ingredient Molnupiravir produced by three Vietnamese manufacturers.
Vietnam now boasts a nationwide healthcare network with 1,665 hospitals, 384 of which are non-public, supported by local commune- and ward-level stations. At the end of 2024, hospital bed capacity reached 34 per 10,000 people, slightly above the global average.
The 56-year-old patient from Quang Tri province was discharged in stable condition as he no longer experienced shortness of breath and was able to walk, move around, and eat normally.
Associate Professor Dr. Nguyen Vu Trung, Director of the Pasteur Institute, said that under the MoU, the two sides committed to promoting diverse and practical collaborative activities, including joint conferences and workshops, exchanges of scholars, researchers and students, sharing academic materials, and the development of specific programmes and projects in scientific research, training, and epidemic prevention.
TytoCare, a leading Israeli telemedicine company based in Netanya, is willing to work with Vietnamese regulators, insurers, and healthcare providers to develop a sustainable digital health ecosystem.
The partnership is under the framework of a Memorandum of Understanding on the development and implementation of the National Action Plan on Breast Cancer and Cervical Cancer Prevention and Control, signed in Hanoi on July 22.
An estimated 7 million Vietnamese are currently living with diabetes, but about 50% remain undiagnosed, a dangerous gap that is fuelling serious, preventable complications and increasing the burden on the healthcare system.
In 2024, Vietnam achieved 99% coverage for the first dose of the diphtheria, tetanus and pertussis vaccine, up from 80% in 2023. Immunisation coverage in the country has not only rebounded to the high levels seen before the COVID-19 pandemic but has now surpassed the rates recorded in 2019.
Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in infections driven by the onset of the rainy season.
During the peak months of July and August 2025, the National Institute of Haematology and Blood Transfusion (NIHBT) needs at least 90,000 units of blood to supply 180 hospitals in the northern region. However, despite continuous efforts, the reserve blood is still short of 30,000 units.
The Hanoi ceremony highlighted efforts to ensure all citizens, especially women and youth, can access accurate information and healthcare services to make informed reproductive choices.
After such a long time, the law has revealed many limitations, prompting the Ministry of Health (MoH) to gather opinions to amend the law to give more chances to thousands of patients every year.
Currently, cardiovascular specialists from the 108 Military Central Hospital are working alongside a team of Prof.Dr. Jan D. Schmitto, Deputy Director of MHH’s Department of Cardiac, Thoracic, Transplantation and Vascular Surgery on clinical trials for MCS devices, implanted in heart failure patients either as a bridge to transplantation or as permanent treatment.
The centre not only serves residents living on the island, but also receives tens of thousands of visitors every year, according to Assoc Prof Dr Tang Chi Thuong, Director of the HCM CIty Department of Health.
Not only does Vietnam attract international tourists with its landscapes, culture, and cuisine, but it is also gradually becoming a reliable destination for medical treatment, offering high-quality services at reasonable costs.
Over the past six months, 150 communal health stations in provinces including Ha Giang, Bac Kan, Lang Son, Lao Cai, Lai Chau, Yen Bai, Tay Ninh, Hau Giang, Ben Tre and Ca Mau have been equipped with information technology systems. In addition, 117 key provincial healthcare workers have received training, with thousands more expected to follow.
During the COVID-19 pandemic in 2020, the Ministry of Health swiftly launched a telemedicine programme, connecting more than 1,000 medical establishments nationwide. The model, which remains in operation, has benefited tens of thousands of patients, including foreign nationals.
After more than three weeks of intensive treatment, the patient's pneumonia improved, breathing stabilised, sedation was reduced, and the breathing tube was removed. He is now conscious, able to eat orally, and in recovery.
There are now four Molnupiravir-based drugs produced in Vietnam approved for domestic use. (Photo: suckhoedoisong.vn) 
